Report Detail

Medical Devices & Consumables Global IPS Cell-derived Platelets Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4627808
  • |
  • 26 September, 2025
  • |
  • Global
  • |
  • 75 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global IPS Cell-derived Platelets market size was valued at US$ 2.2 million in 2024 and is forecast to a readjusted size of USD 3.1 million by 2031 with a CAGR of 5.5% during review period.
iPS cell-derived platelets are platelets that are differentiated from induced pluripotent stem cells (iPS cells). iPS cells are a type of pluripotent stem cells that are reprogrammed into adult somatic cells (such as skin cells) with similar properties to embryonic stem cells by transfecting specific genes. iPS cells can differentiate into any cell type in the body, including blood cells. In this context, iPS cell-derived platelets refer to platelets that are produced by culturing precursor cells derived from iPS cells (such as platelet-producing megakaryocytes). These platelets can be cultured in vitro and used in the medical field to replace donor platelets, especially for the treatment of diseases caused by insufficient platelet count or abnormal function.
iPS cell-derived platelets, as an important breakthrough in the field of regenerative medicine, have received widespread attention in recent years. iPS cells (induced pluripotent stem cells) have extremely strong differentiation potential and can generate pluripotent stem cells similar to embryonic stem cells by reprogramming adult somatic cells. This technology not only provides new ideas for cell therapy and tissue repair, but also opens up new directions for the production of blood products. By deriving platelets from iPS cells, new treatment options can be provided for patients with diseases such as platelet deficiency and platelet dysfunction, and the problem of global shortage of blood products can also be alleviated.
At present, the research on iPS cell-derived platelets is still in its early stages, and many research institutions and biotechnology companies are committed to the development and optimization of this technology. Platelets, as a cell with special functions, are responsible for hemostasis and coagulation in the body, so the safety and effectiveness of their clinical application are crucial.
At present, the research on iPS cell-derived platelets is mainly concentrated in the laboratory and preclinical stages. Some research institutions and biopharmaceutical companies in Japan, the United States and Europe have made some progress in this field. However, the current production of iPS cell-derived platelets still faces some difficulties, including complex production processes, high costs, and the fact that the functions of platelets are still different from those of natural platelets.
Despite this, the prospects for the iPS cell-derived platelet market are still broad. The global blood products market has grown year by year, but the shortage of platelet supply has always been an issue that cannot be ignored. A large number of platelets are needed every year to meet clinical needs, especially in groups such as cancer patients, blood disease patients, and surgical patients. Traditional blood products rely on voluntary donors, but due to the limited number of donors, the supply of platelets is often in short supply. The emergence of iPS cell-derived platelets may break this limitation and provide a more stable and efficient alternative to meet market demand.
This report is a detailed and comprehensive analysis for global IPS Cell-derived Platelets market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IPS Cell-derived Platelets market size and forecasts, in consumption value ($ Million), 2020-2031
Global IPS Cell-derived Platelets market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global IPS Cell-derived Platelets market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global IPS Cell-derived Platelets market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IPS Cell-derived Platelets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IPS Cell-derived Platelets market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Megakaryon Corporation, Renerval Therapeutics, Xueji Shengwu, Help Therapeutics, Cynata Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
IPS Cell-derived Platelets market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
In Vivo Regeneration
In Vitro Regeneration
Market segment by Application
Cancer
Blood Disease
Others
Market segment by players, this report covers
Megakaryon Corporation
Renerval Therapeutics
Xueji Shengwu
Help Therapeutics
Cynata Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IPS Cell-derived Platelets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IPS Cell-derived Platelets, with revenue, gross margin, and global market share of IPS Cell-derived Platelets from 2020 to 2025.
Chapter 3, the IPS Cell-derived Platelets competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and IPS Cell-derived Platelets market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IPS Cell-derived Platelets.
Chapter 13, to describe IPS Cell-derived Platelets research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of IPS Cell-derived Platelets by Type
    • 1.3.1 Overview: Global IPS Cell-derived Platelets Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global IPS Cell-derived Platelets Consumption Value Market Share by Type in 2024
    • 1.3.3 In Vivo Regeneration
    • 1.3.4 In Vitro Regeneration
  • 1.4 Global IPS Cell-derived Platelets Market by Application
    • 1.4.1 Overview: Global IPS Cell-derived Platelets Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cancer
    • 1.4.3 Blood Disease
    • 1.4.4 Others
  • 1.5 Global IPS Cell-derived Platelets Market Size & Forecast
  • 1.6 Global IPS Cell-derived Platelets Market Size and Forecast by Region
    • 1.6.1 Global IPS Cell-derived Platelets Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global IPS Cell-derived Platelets Market Size by Region, (2020-2031)
    • 1.6.3 North America IPS Cell-derived Platelets Market Size and Prospect (2020-2031)
    • 1.6.4 Europe IPS Cell-derived Platelets Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific IPS Cell-derived Platelets Market Size and Prospect (2020-2031)
    • 1.6.6 South America IPS Cell-derived Platelets Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa IPS Cell-derived Platelets Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Megakaryon Corporation
    • 2.1.1 Megakaryon Corporation Details
    • 2.1.2 Megakaryon Corporation Major Business
    • 2.1.3 Megakaryon Corporation IPS Cell-derived Platelets Product and Solutions
    • 2.1.4 Megakaryon Corporation IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Megakaryon Corporation Recent Developments and Future Plans
  • 2.2 Renerval Therapeutics
    • 2.2.1 Renerval Therapeutics Details
    • 2.2.2 Renerval Therapeutics Major Business
    • 2.2.3 Renerval Therapeutics IPS Cell-derived Platelets Product and Solutions
    • 2.2.4 Renerval Therapeutics IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Renerval Therapeutics Recent Developments and Future Plans
  • 2.3 Xueji Shengwu
    • 2.3.1 Xueji Shengwu Details
    • 2.3.2 Xueji Shengwu Major Business
    • 2.3.3 Xueji Shengwu IPS Cell-derived Platelets Product and Solutions
    • 2.3.4 Xueji Shengwu IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Xueji Shengwu Recent Developments and Future Plans
  • 2.4 Help Therapeutics
    • 2.4.1 Help Therapeutics Details
    • 2.4.2 Help Therapeutics Major Business
    • 2.4.3 Help Therapeutics IPS Cell-derived Platelets Product and Solutions
    • 2.4.4 Help Therapeutics IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Help Therapeutics Recent Developments and Future Plans
  • 2.5 Cynata Therapeutics
    • 2.5.1 Cynata Therapeutics Details
    • 2.5.2 Cynata Therapeutics Major Business
    • 2.5.3 Cynata Therapeutics IPS Cell-derived Platelets Product and Solutions
    • 2.5.4 Cynata Therapeutics IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Cynata Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global IPS Cell-derived Platelets Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of IPS Cell-derived Platelets by Company Revenue
    • 3.2.2 Top 3 IPS Cell-derived Platelets Players Market Share in 2024
    • 3.2.3 Top 6 IPS Cell-derived Platelets Players Market Share in 2024
  • 3.3 IPS Cell-derived Platelets Market: Overall Company Footprint Analysis
    • 3.3.1 IPS Cell-derived Platelets Market: Region Footprint
    • 3.3.2 IPS Cell-derived Platelets Market: Company Product Type Footprint
    • 3.3.3 IPS Cell-derived Platelets Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global IPS Cell-derived Platelets Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global IPS Cell-derived Platelets Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global IPS Cell-derived Platelets Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global IPS Cell-derived Platelets Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America IPS Cell-derived Platelets Consumption Value by Type (2020-2031)
  • 6.2 North America IPS Cell-derived Platelets Market Size by Application (2020-2031)
  • 6.3 North America IPS Cell-derived Platelets Market Size by Country
    • 6.3.1 North America IPS Cell-derived Platelets Consumption Value by Country (2020-2031)
    • 6.3.2 United States IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 6.3.3 Canada IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico IPS Cell-derived Platelets Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe IPS Cell-derived Platelets Consumption Value by Type (2020-2031)
  • 7.2 Europe IPS Cell-derived Platelets Consumption Value by Application (2020-2031)
  • 7.3 Europe IPS Cell-derived Platelets Market Size by Country
    • 7.3.1 Europe IPS Cell-derived Platelets Consumption Value by Country (2020-2031)
    • 7.3.2 Germany IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 7.3.3 France IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 7.3.5 Russia IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 7.3.6 Italy IPS Cell-derived Platelets Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific IPS Cell-derived Platelets Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific IPS Cell-derived Platelets Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific IPS Cell-derived Platelets Market Size by Region
    • 8.3.1 Asia-Pacific IPS Cell-derived Platelets Consumption Value by Region (2020-2031)
    • 8.3.2 China IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 8.3.3 Japan IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 8.3.5 India IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 8.3.7 Australia IPS Cell-derived Platelets Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America IPS Cell-derived Platelets Consumption Value by Type (2020-2031)
  • 9.2 South America IPS Cell-derived Platelets Consumption Value by Application (2020-2031)
  • 9.3 South America IPS Cell-derived Platelets Market Size by Country
    • 9.3.1 South America IPS Cell-derived Platelets Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina IPS Cell-derived Platelets Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa IPS Cell-derived Platelets Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa IPS Cell-derived Platelets Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa IPS Cell-derived Platelets Market Size by Country
    • 10.3.1 Middle East & Africa IPS Cell-derived Platelets Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia IPS Cell-derived Platelets Market Size and Forecast (2020-2031)
    • 10.3.4 UAE IPS Cell-derived Platelets Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 IPS Cell-derived Platelets Market Drivers
  • 11.2 IPS Cell-derived Platelets Market Restraints
  • 11.3 IPS Cell-derived Platelets Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 IPS Cell-derived Platelets Industry Chain
  • 12.2 IPS Cell-derived Platelets Upstream Analysis
  • 12.3 IPS Cell-derived Platelets Midstream Analysis
  • 12.4 IPS Cell-derived Platelets Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on IPS Cell-derived Platelets. Industry analysis & Market Report on IPS Cell-derived Platelets is a syndicated market report, published as Global IPS Cell-derived Platelets Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of IPS Cell-derived Platelets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report